Grant: Engage Grants Program
University of Guelph
$25,000.00
Agrobacterium bioreactor culture for PlantForm vivoEXPRESS enhancement
EF 2016-17
Résumé
Plants, in particular the tobacco relative Nicotiana benthamiana, are increasingly being used as a productionplatform for therapeutic proteins such as monoclonal antibodies, enzymes, and vaccines. The benefits includereduced cost of drug products, very rapid delivery of new products to the market, and capability to provide safeand efficacious medicines for diseases such as cancer. PlantForm Corporation is a Canadian biotechnologycompany using this system to develop biosimilar versions of therapeutics such as Herceptin? as well asinnovative products as countermeasures against emerging diseases like Ebola. The basis of the PlantFormtechnology (developed at the University of Guelph) - vivoXPRESS? - is to use a common plant pathogen(Agrobacterium tumefaciens) to deliver the genes encoding the product to cells of a whole plant such that theplant becomes a factory for manufacture of the product. The system is described as transient expressionbecause the infected plants are all sacrificed to recover product - there is no phase of propagation of theinfected plants. In this system, the bacterium is prepared fresh for each production batch. The preparation ofplants (from a master seed stock) uses a well-established hydroponic method. The growth of the bacterium is,conversely, not particularly well developed. The current approach is to use a simple shake flask system,increasing the number of flasks used to increase the scale of the manufactured batch of product (i.e., to infectmore plants). Such methods are inefficient and difficult to control, making for an unacceptable productionprocess as scale-up is challenging and the possibilities for both variability and contamination in the infectionprocess are high. This project aims to improve the efficiency and reliability of this process by determiningoptimal methods for Agrobacterium culture using a bioreactor system to enhance microbial biomass andimprove its infectivity. It is anticipated that outcomes of this project will provide procedures for PlantForm toreliably control bacterial growth-regulating parameters such as pH and dissolved oxygen, resulting inreproducible cultures and reduced risk of process failure.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
507653-2016
Name nom
AllenVercoe, Emma
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
Agrobacterium bioreactor culture for PlantForm vivoEXPRESS enhancement
Keyword
NSERC
Application summary
Plants, in particular the tobacco relative Nicotiana benthamiana, are increasingly being used as a productionplatform for therapeutic proteins such as monoclonal antibodies, enzymes, and vaccines. The benefits includereduced cost of drug products, very rapid delivery of new products to the market, and capability to provide safeand efficacious medicines for diseases such as cancer. PlantForm Corporation is a Canadian biotechnologycompany using this system to develop biosimilar versions of therapeutics such as Herceptin? as well asinnovative products as countermeasures against emerging diseases like Ebola. The basis of the PlantFormtechnology (developed at the University of Guelph) - vivoXPRESS? - is to use a common plant pathogen(Agrobacterium tumefaciens) to deliver the genes encoding the product to cells of a whole plant such that theplant becomes a factory for manufacture of the product. The system is described as transient expressionbecause the infected plants are all sacrificed to recover product - there is no phase of propagation of theinfected plants. In this system, the bacterium is prepared fresh for each production batch. The preparation ofplants (from a master seed stock) uses a well-established hydroponic method. The growth of the bacterium is,conversely, not particularly well developed. The current approach is to use a simple shake flask system,increasing the number of flasks used to increase the scale of the manufactured batch of product (i.e., to infectmore plants). Such methods are inefficient and difficult to control, making for an unacceptable productionprocess as scale-up is challenging and the possibilities for both variability and contamination in the infectionprocess are high. This project aims to improve the efficiency and reliability of this process by determiningoptimal methods for Agrobacterium culture using a bioreactor system to enhance microbial biomass andimprove its infectivity. It is anticipated that outcomes of this project will provide procedures for PlantForm toreliably control bacterial growth-regulating parameters such as pH and dissolved oxygen, resulting inreproducible cultures and reduced risk of process failure.